NFE2L2 and hepatocellular carcinoma: Cumulative evidence indicated that several natural molecules exerted hepatoprotective effects through activating the Keap1–Nrf2 pathway, which implied that the activation of this pathway might protect against erastin-induced ferroptosis in hepatocellular carcinoma (HCC) cells28,29.